hrvatski jezikClear Cookie - decide language by browser settings

Differential Effects of Integrin αv Knockdown and Cilengitide on Sensitization of Triple-Negative Breast Cancer and Melanoma Cells to Microtubule Poisons

Stojanović, Nikolina; Dekanić, Ana; Paradžik, Mladen; Majhen, Dragomira; Ferenčak, Krešimir; Ruščić, Jelena; Bardak, Irena; Supina, Christine; Tomicic, Maja T.; Christmann, Markus; Osmak, Maja; Ambriović-Ristov, Andreja (2018) Differential Effects of Integrin αv Knockdown and Cilengitide on Sensitization of Triple-Negative Breast Cancer and Melanoma Cells to Microtubule Poisons. Molecular Pharmacology, 94 (6). pp. 1334-1351. ISSN 0026-895X

| Request a personal copy from author | Request a personal copy from author


Low survival rates of patients with metastatic triple-negative breast cancer (TNBC) and melanoma, in which current therapies are ineffective, emphasize the need for new therapeutic approaches. Integrin β1 appears to be a promising target when combined with chemotherapy, but recent data have shown that its inactivation increases metastatic potential owing to the compensatory upregulation of other integrin subunits. Consequently, we analyzed the potential of integrin subunits αv, α3, or α4 as targets for improved therapy in seven TNBC and melanoma cell lines. Experiments performed in an integrin αvβ1-negative melanoma cell line, MDA-MB-435S, showed that knockdown of integrin subunit αv increased sensitivity to microtubule poisons vincristine or paclitaxel and decreased migration and invasion. In the MDA-MB-435S cell line, we also identified a phenomenon in which change in the expression of one integrin subunit changes the expression of other integrins, leading to an unpredictable influence on sensitivity to anticancer drugs and cell migration, referred to as the integrin switching effect. In a panel of six TNBCs and melanoma cell lines, the contribution of integrins αv versus integrins αvβ3/β5 was assessed by the combined action of αv-specific small interfering RNA or αvβ3/β5 inhibitor cilengitide with paclitaxel. Our results suggest that, for TNBC, knockdown of integrin αv in combination with paclitaxel presents a better therapeutic option than a combination of cilengitide with paclitaxel; however, in melanoma, neither of these combinations is advisable because a decreased sensitivity to paclitaxel was observed.

Item Type: Article
Uncontrolled Keywords: integrins; integrin αv; integrin α4; integrin α3; integrin knockdown; cilengitide; PF-228; phospho FAK; sensitization; triple-negative breast cancer; melanoma cells; paclitaxel; vincristine; cisplatin; integrin switching; integrin crosstalk
Subjects: NATURAL SCIENCES > Biology
NATURAL SCIENCES > Biology > Biochemistry and Molecular Biology
Divisions: Division of Molecular Biology
Project titleProject leaderProject codeProject type
Povećanje osjetljivosti stanica melanoma i glioma na alkilirajuće lijekove utišavanjem integrina αvβ3, αvβ5, α3β1 i α4β1Andreja Ambriović RistovUNSPECIFIEDThe bilateral program Deutscher Akademischer Austausch Dienst
Povećanje transdukcije adenovirusnih vektora i otpornost stanica na citostatike-Andreja Ambriović Ristov098-0982913-2850MZOS
Depositing User: Ana Tadijan
Date Deposited: 26 Nov 2019 11:47
DOI: 10.1124/mol.118.113027

Actions (login required)

View Item View Item


Downloads per month over past year

Increase Font
Decrease Font
Dyslexic Font